Kompauto Nordic AB

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Speed meets precision for high-density components

ZEISS METROTOM 800 320 kV.

Gilead står fast vid hivsatsning – trots hotad finansiering

Gilead Sciences planerar fortfarande att leverera sitt hiv-läkemedel till låginkomstländer om det godkänns i USA, trots osäker finansiering efter Trumpadministr...

A new life science cluster formed – “We are very strong in talent”

Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

Biogen's Alzheimer's candidate BIIB080 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

Novo Nordisk vill ha skadestånd efter misslyckat miljardförvärv

Novo Nordisk vill ha ett skadestånd på upp till 830 miljoner dollar från KBP Biosciences, enligt ett domslut från en domstol i Singapore.

The new Swedish life science strategy – “It will consolidate Sweden as a leader”

Clinical trials and precision health are emphasised as key areas in the new national life science strategy.

Tung patentutgång får Novartis att banta personalstyrkan

Novartis planerar att kapa bort 427 tjänster i USA, bland annat till följd av en kommande patentutgång för bolagets hjärtläkemedel Entresto.

Microscopy in Urinalysis: Observe Urine, Detect Abnormalities

Webinar on 18th March 2025, 10 AM - 11 AM CET.

Svenske Martin Kulldorff bland nya vaccinrådgivare – utnämnd av Kennedy

USA:s hälsominister Robert Kennedy Jr. utsåg på onsdagen åtta nya ledamöter till CDC:s rådgivande vaccinkommitté (ACIP), efter att plötsligt ha avskedat hela de...

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

Misslyckande för BMS i sen studie om hjärtläkemedel

Läkemedelsjätten Bristol Myers Squibbs läkemedel mot en typ av hjärtsjukdom misslyckades i en sen klinisk studie. Det svaga utfallet ökar kraven på positiva utf...

Improving Nano-Structured Surfaces for Implants with Scanning Electron Microscopy

Promimic, a Swedish company specializing in the development and marketing of nano-structured surfaces for implants, heavily relies on scanning electron microscopes.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Success for Genmab's antibody-drug conjugate

The Danish company Genmab has received Japanese approval for its treatment for advanced or recurrent cervical cancer.

The new ZEISS Celldiscoverer 7 has been launched

Adaptable automation for advanced workflows.

Danish biotech to buy struggling American oncology company

Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

Canada approves leqembi as global alzheimer’s drug race heats up

Leqembi has secured approval in Canada, further consolidating its global lead among disease-modifying Alzheimer’s therapies. The antibody is now authorized in 1...

Several departures at the top at Nykode

Members of both the management and the board are leaving the Norwegian biotech company Nykode.

Sobi går om Roche i ny patientrankning

Roche tappar förstaplatsen i Patientviews årliga rankning över läkemedelsföretagens anseende bland patientorganisationer inom sällsynta sjukdomar. Nykomlingen S...